Suministro de medicamentos principios activos: INTERFERON BETA 1-A, CANNABINOL-RONABINOL Y AVELUMAB, dispensados en el Hospital Universitario dependiente del INGESA para los pacientes de la Gerencia de Atención Sanitaria de Melilla.
cn-standardContract or concession notice – standard regime00378009-2026GSGerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria
Estimated value€690,935
DeadlineExpired1 Jul 2026, 21:59
Competition00 participants
Lots33 lots
Track this opportunity
Register to add pursuits, save this notice, and get alerts when similar tenders appear.
- Save and reuse search filters
- Track opportunities as pursuits
- Get notified when new notices match
Quick actions
Key information
Identifier
00378009-2026
Contract type
—
Deadline
1 Jul 2026, 21:59
CPV codes
33600000 - Pharmaceutical products
Status
Active
Notice type
cn-standardContract or concession notice – standard regime
Source
Estimated value
€690,935
Publication date
1 Jun 2026, 22:00
Overview
Suministro de medicamentos principios activos: INTERFERON BETA 1-A, CANNABINOL-RONABINOL Y AVELUMAB, dispensados en el Hospital Universitario dependiente del INGESA para los pacientes de la Gerencia de Atención Sanitaria de Melilla.
Quick actions
Timeline
01 Jun 2026, 12:29
Dispatch date
Milestone
01 Jun 2026, 22:00
Publication date
Publication
01 Jul 2026, 21:59
Submission deadline
Deadline
Version history
None recorded.
Lots3
Documentation0
The source system does not support document syncing.
Award criteria0
No procedure-level award criteria recorded.